Learn More
Cayman Chemical ANTIBODY CeapIn-A7 50mg

Supplier: Cayman Chemical 3611350 MG
An ATF6α inhibitor (IC50 = 0.59 µM in a reporter assay); selective for ATF6α over ATF6β at 18.9 µM; sensitizes U2OS cells to thapsigargin; chondrocyte-conditioned media from primary human chondrocytes pre-incubated with ceapin-A7 (0.5 µM) prior to stimulation with TNF-α, IFN-γ, or IL-17 has a reduced ability to induce tube formation in HUVECs; inhibits viral RNA production in Vero cells infected with SARS-CoV-2 at 15 µM
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.